Cargando…
Impairment of Quality of Life among Patients with Wearable Cardioverter Defibrillator Therapy (LifeVest®): A Preliminary Study
BACKGROUND: Wearable cardioverter defibrillator (WCD) therapy is feasible and safe in patients as a transient protection against sudden cardiac death (SCD). However, the impact of WCD therapy on quality of life (QoL) has not been studied. METHODS: In our single-centre study, 109 consecutive patients...
Autores principales: | Lackermair, Korbinian, Schuhmann, Christoph G., Kubieniec, Michaela, Riesinger, Lisa M., Klier, Ina, Stocker, Thomas J., Kääb, Stefan, Estner, Heidi L., Fichtner, Stephanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6040298/ https://www.ncbi.nlm.nih.gov/pubmed/30050939 http://dx.doi.org/10.1155/2018/6028494 |
Ejemplares similares
-
Impairment of Quality of Life in Patients with Implanted Subcutaneous Cardioverter Defibrillator (S-ICD) Compared to Implanted Transvenous Cardioverter Defibrillator Therapy
por: Thienel, Manuela, et al.
Publicado: (2022) -
Evaluation of a Standardized Training and Adherence Surveillance Programme to Overcome Quality-of-Life Impairments and Enhance Compliance in Patients Treated with Wearable Cardioverter Defibrillator
por: Kellnar, Antonia, et al.
Publicado: (2023) -
Wearable cardioverter defibrillator: A life vest till the life boat (ICD) arrives
por: Francis, Johnson, et al.
Publicado: (2014) -
Impact of lead detecting algorithms on inappropriate shocks in implantable cardioverter defibrillator lead failure: a single-center manufacturer-independent observational study
por: Lemmermöhle, Eric, et al.
Publicado: (2022) -
Wearable cardioverter-defibrillator (life-vest): A feasible bridging treatment in adult congenital heart disease
por: Sarubbi, Berardo, et al.
Publicado: (2022)